The National Institute of Neurological Disorders and Stroke (NINDS) offers the Cooperative Program in Translational Research – Small Business Awards (SBIR [U44]) to support Phase II and Fast-Track SBIR projects focusing on developing new therapeutics for neurological disorders. Projects must involve therapeutic leads with proven activity against the target disease, aiming to advance them for IND or IDE application submission by project completion. This milestone-driven cooperative agreement program excludes early-stage therapeutic discovery, clinical research, and basic research activities. Utilizing the SBIR Cooperative Agreements (U44) grant mechanism, the total funding and number of awards will depend on the quality and costs of the applications received. Closing date: Sep 07, 2011.
Opportunity ID: 44975
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-235 |
| Funding Opportunity Title: | NINDS Cooperative Program in Translational Research – Small Business Awards (SBIR [U44]) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 26, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2011 |
| Current Closing Date for Applications: | Sep 07, 2011 |
| Archive Date: | Oct 08, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA requests applications Phase II and Fast-Track SBIR cooperative agreement projects that directly address the identification and pre-clinical testing of new therapeutics for neurological disorders. The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports pre-clinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. -Mechanism of Support. This FOA will utilize the SBIR Cooperative Agreements (U44) grant mechanism for Phase II and Fast-Track applications. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-235.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modified title | – | |
| Jan 26, 2009 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-235 |
| Funding Opportunity Title: | NINDS Cooperative Program in Translational Research – Small Business Awards (SBIR [U44]) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 26, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2011 |
| Current Closing Date for Applications: | Sep 07, 2011 |
| Archive Date: | Oct 08, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA requests applications Phase II and Fast-Track SBIR cooperative agreement projects that directly address the identification and pre-clinical testing of new therapeutics for neurological disorders. The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports pre-clinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. -Mechanism of Support. This FOA will utilize the SBIR Cooperative Agreements (U44) grant mechanism for Phase II and Fast-Track applications. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-235.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-08-235 |
| Funding Opportunity Title: | NINDS Cooperative Program in Translational Research Small Business Awards (SBIR [U44]) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 26, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Sep 07, 2011 |
| Archive Date: | Oct 08, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | -Purpose. This FOA requests applications Phase II and Fast-Track SBIR cooperative agreement projects that directly address the identification and pre-clinical testing of new therapeutics for neurological disorders. The program will facilitate solicitation, development, and review of therapy-directed projects to accelerate the translation of basic research discoveries into therapeutic candidates for clinical testing. This program is specifically directed at projects that include therapeutic leads with demonstrated activity against the intended disease target. The program supports pre-clinical optimization and testing of these leads and projects must be sufficiently advanced that an IND or IDE application to the FDA can be submitted by the end of the project period. The program does not support early-stage therapeutic discovery activities such as high throughput screening. The program also excludes clinical research, basic research, and studies of disease mechanism. This is a milestone-driven cooperative agreement program involving participation of NINDS staff in the development of the project plan and monitoring of research progress. -Mechanism of Support. This FOA will utilize the SBIR Cooperative Agreements (U44) grant mechanism for Phase II and Fast-Track applications. -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-08-235.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.853 | ADOBE-FORMS-A | Adobe-Forms-A | PKG00010185 | Jan 26, 2009 | Mar 04, 2010 | View |
| 93.853 | ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00016877 | Mar 05, 2010 | Nov 05, 2010 | View |
| 93.853 | ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00022418 | Nov 05, 2010 | Sep 07, 2011 | View |
Package 1
Mandatory forms
44975 RR_SF424-1.1.pdf
44975 RR_KeyPersonExpanded-1.1.pdf
44975 RR_OtherProjectInfo-1.1.pdf
44975 RR_PerformanceSite-1.1.pdf
44975 RR_Budget-1.1.pdf
44975 SBIR_STTR_Information-1.0.pdf
44975 PHS398_CoverPageSupplement-1.1.pdf
44975 PHS398_ResearchPlan-1.1.pdf
44975 PHS398_Checklist-1.1.pdf
Optional forms
44975 PHS398_CoverLetter-1.1.pdf
44975 RR_SubawardBudget-1.2.pdf
Package 2
Mandatory forms
44975 RR_SF424_1_2-1.2.pdf
44975 SBIR_STTR_Information_1_1-1.1.pdf
44975 PerformanceSite_1_3-1.3.pdf
44975 RR_OtherProjectInfo_1_2-1.2.pdf
44975 RR_KeyPersonExpanded_1_2-1.2.pdf
44975 RR_Budget-1.1.pdf
44975 PHS398_CoverPageSupplement_1_4-1.4.pdf
44975 PHS398_ResearchPlan_1_3-1.3.pdf
44975 PHS398_Checklist_1_3-1.3.pdf
Optional forms
44975 PHS_CoverLetter_1_2-1.2.pdf
44975 RR_SubawardBudget-1.2.pdf
Package 3
Mandatory forms
44975 RR_SF424_1_2-1.2.pdf
44975 SBIR_STTR_Information_1_1-1.1.pdf
44975 RR_OtherProjectInfo_1_3-1.3.pdf
44975 RR_KeyPersonExpanded_1_2-1.2.pdf
44975 RR_Budget-1.1.pdf
44975 PerformanceSite_1_4-1.4.pdf
44975 PHS398_ResearchPlan_1_3-1.3.pdf
44975 PHS398_CoverPageSupplement_1_4-1.4.pdf
44975 PHS398_Checklist_1_3-1.3.pdf
Optional forms
44975 RR_SubawardBudget-1.2.pdf
44975 PHS_CoverLetter_1_2-1.2.pdf
Leave a Reply